Skip to main content
Log in

Relation of risk factors and putative premotor markers for Parkinson’s disease

  • Movement Disorders - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

As both risk and premotor markers are increasingly discussed to play a key role in the pre-diagnostic phase of Parkinson’s disease (PD) the aim of this study was to determine the relation between the risk factors hyperechogenicity of the substantia nigra (SN+) and/or positive family history of PD (faPD+) and putative premotor markers for PD. In a cross-sectional analysis of data of the PRIPS cohort, 1,149 volunteers older than 50 years free of PD were included. In addition to the risk factors SN+ and faPD+, olfactory dysfunction was tested using the Sniffin’ sticks test and motor examination was performed. History of depression and constipation was evaluated by a semi-structured interview. Of all 1,149 individuals, 880 had none of the risk markers (76.6%), 143 persons (12.4%) had SN+, 84 (7.3%) were classified as faPD+ and 42 (3.7%) persons had both risk factors. Volunteers with SN+ showed olfactory dysfunction and mild motor impairment (p ≤ 0.001) more often. Depression was more prominent in individuals having two risk factors (p = 0.05). An accumulation of premotor markers was seen in the SN+ group with or without concomitant faPD+, but not in persons with faPD+ only. The profile of premotor markers seems to differ in participants having SN+ and/or faPD+, with SN+ showing the overall highest association with most premotor markers, which implies that SN+ might be a strong indicator for a neurodegenerative process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alonso A, Rodriguez LA, Logroscino G, Hernan MA (2009) Use of antidepressants and the risk of Parkinson’s disease: a prospective study. J Neurol Neurosurg Psychiatry 80:671–674

    Article  PubMed  CAS  Google Scholar 

  • Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ (2005) Gender and the Parkinson’s disease phenotype. J Neurol 252:1201–1205

    Article  PubMed  Google Scholar 

  • Behnke S, Double KL, Duma S, Broe GA, Guenther V, Becker G et al (2007) Substantia nigra echomorphology in the healthy very old: correlation with motor slowing. Neuroimage 34:1054–1059

    Article  PubMed  CAS  Google Scholar 

  • Berg D (2008) Biomarkers for the early detection of Parkinson’s and Alzheimer’s disease. Neurodegener Dis 5:133–136

    Article  PubMed  Google Scholar 

  • Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M et al (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53:1026–1031

    PubMed  CAS  Google Scholar 

  • Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G (2001a) Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50:463–467

    Article  PubMed  CAS  Google Scholar 

  • Berg D, Siefker C, Ruprecht-Dorfler P, Becker G (2001b) Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56:13–17

    PubMed  CAS  Google Scholar 

  • Berg D, Roggendorf W, Schroder U, Klein R, Tatschner T, Benz P et al (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999–1005

    Article  PubMed  Google Scholar 

  • Berg D, Seppi K, Liepelt I, Schweitzer K, Wollenweber F, Wolf B, et al (2010) Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly. Mov Disord 25(10):1464–1469

    Google Scholar 

  • Brooks DJ (1998) The early diagnosis of Parkinson’s disease. Ann Neurol 44:S10–S18

    Article  PubMed  CAS  Google Scholar 

  • de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2006) Subjective complaints precede Parkinson disease: the rotterdam study. Arch Neurol 63:362–365

    Article  PubMed  Google Scholar 

  • de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG et al (1995) Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology 45:2143–2146

    PubMed  Google Scholar 

  • Elbaz A, Grigoletto F, Baldereschi M, Breteler MM, Manubens-Bertran JM, Lopez-Pousa S et al (1999) Familial aggregation of Parkinson’s disease: a population-based case-control study in Europe EUROPARKINSON Study Group. Neurology 52:1876–1882

    PubMed  CAS  Google Scholar 

  • Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283–2301

    Article  PubMed  Google Scholar 

  • Gasser T (2007) Update on the genetics of Parkinson’s disease. Mov Disord 22(Suppl 17):S343–S350

    Article  PubMed  Google Scholar 

  • Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752

    Article  PubMed  CAS  Google Scholar 

  • Hagenah JM, Becker B, Bruggemann N, Djarmati A, Lohmann K, Sprenger A et al (2008) Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations. J Neurol Neurosurg Psychiatry 79:1071–1074

    Article  PubMed  CAS  Google Scholar 

  • Hummel T, Konnerth CG, Rosenheim K, Kobal G (2001) Screening of olfactory function with a 4-min odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110:976–981

    PubMed  CAS  Google Scholar 

  • Kaufmann H, Nahm K, Purohit D, Wolfe D (2004) Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63:1093–1095

    PubMed  Google Scholar 

  • Kurz M, Alves G, Aarsland D, Larsen JP (2003) Familial Parkinson’s disease: a community-based study. Eur J Neurol 10:159–163

    Article  PubMed  CAS  Google Scholar 

  • Liepelt I, Behnke S, Schweitzer K, Wolf B, Godau J, Wollenweber F, et al (2009) Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population. Neurobiol Aging (in press)

  • Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I et al (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486

    Article  PubMed  Google Scholar 

  • Louis ED, Tang MX, Schupf N, Mayeux R (2005) Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol 62:297–302

    Article  PubMed  Google Scholar 

  • Marder K, Tang MX, Mejia H, Alfaro B, Cote L, Louis E et al (1996) Risk of Parkinson’s disease among first-degree relatives: a community-based study. Neurology 47:155–160

    PubMed  CAS  Google Scholar 

  • Preux PM, Condet A, Anglade C, Druet-Cabanac M, Debrock C, Macharia W et al (2000) Parkinson’s disease and environmental factors matched case-control study in the Limousin region, France. Neuroepidemiology 19:333–337

    Article  PubMed  CAS  Google Scholar 

  • Przuntek H, Muller T, Riederer P (2004) Diagnostic staging of Parkinson’s disease: conceptual aspects. J Neural Transm 111:201–216

    Article  PubMed  CAS  Google Scholar 

  • Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K et al (2008) Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 63:167–173

    Article  PubMed  Google Scholar 

  • Ruprecht-Dorfler P, Berg D, Tucha O, Benz P, Meier-Meitinger M, Alders GL et al (2003) Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson’s disease. Neuroimage 18:416–422

    Article  PubMed  Google Scholar 

  • Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB (2007) Risk factors for Parkinson’s disease and impaired olfaction in relatives of patients with Parkinson’s disease. Mov Disord 22:2249–2255

    Article  PubMed  Google Scholar 

  • Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J et al (2004) Detection of presymptomatic Parkinson’s disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19:1196–1202

    Article  PubMed  Google Scholar 

  • Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D (2004) Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19:1445–1449

    Article  PubMed  Google Scholar 

  • Walter U, Behnke S, Eyding J, Niehaus L, Postert T, Seidel G et al (2007a) Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 33:15–25

    Article  PubMed  Google Scholar 

  • Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R (2007b) Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130:1799–1807

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Berg.

Additional information

I. Liepelt-Scarfone and S. Behnke contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liepelt-Scarfone, I., Behnke, S., Godau, J. et al. Relation of risk factors and putative premotor markers for Parkinson’s disease. J Neural Transm 118, 579–585 (2011). https://doi.org/10.1007/s00702-010-0553-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-010-0553-x

Keywords

Navigation